Navigation Links
For Medical Device Makers, Full Spectrum Software Presents a Live, One Hour Audio Course on Implementing QA Automation in an FDA Controlled Environment
Date:7/22/2009

For medical device makers, Full Spectrum Software presents a live, one hour audio course on Implementing QA Automation in an FDA Controlled Environment. The event is hosted by Foreign Exchange Translations. detailed information on the course can be found here

Southborough, MA and Halifax, NS (Vocus) July 22, 2009 -- Sponsored by Foreign Exchange Translations, Full Spectrum Software will present a live, one hour audio course on August 11th at 11:30 EDT. With major changes expected at the FDA, including increased scrutiny of complex medical devices, automating the QA process for medical device companies is more important than ever. This live, one hour audio presentation provides medical device software engineering and medical device QA professionals with practical guidelines on how to successfully implement QA automation in an FDA controlled software environment. The speaker discusses how to select and implement the correct tools, how to validate those tools and how to work with technical teams to develop the cost justification for automating the QA process.

This live one hour event is sponsored by Foreign Exchange Translations, leaders in medical translations and producers of dozens of live audio events of interest to the biotechnology and medical device industry. Full Spectrum Software, a national medical device software engineering and QA consulting firms and a recognized authority on both medical device software QA automation as well as medical device software engineering was selected by Foreign Exchange Translations to develop and present this live, one hour audio event. more information and a full course description can be found here

The live, one hour audio course will also feature a discussion of the FDA’s use of Static Analysis tools and the controversy surrounding some of the public statements made by the FDA. More importantly, the course will cover what the implications of these statements by the FDA mean to medical device companies and how this could impact the software QA processes.

About Foreign Exchange Translations
Foreign Exchange Translations, a leader in medical translations, has come to know how products are created, from R&D to clinical trials to marketing and all the steps in between. Their knowledge of the product life cycle means that they can speak the same language as their clients and build language translation into the process. Foreign Exchange Translations also hosts dozens of audio conferences every year that are of interest to the biotechnology and medical device community. You can find more information on their website more information on Foreign Exchange Translations here

###

Read the full story at http://www.prweb.com/releases/2009QA/7automation/prweb2649324.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Varian Medical Systems Receives 510(k) Clearance for Fast and Accurate Acuros(TM) Radiotherapy Treatment Planning Capability
2. Symmetry Medical to Report Second Quarter 2009 Financial Results on August 6, 2009
3. Lumenis, Worlds Largest Medical Laser Company, Honored by Premier Healthcare Alliance for Exceeding Performance Expectations
4. Rochester Medical Announces Third Quarter 2009 Earnings Conference Call July 30, 2009
5. Greenway Medical Technologies Executive, Justin Barnes, Re-Elected As Chairman of HIMSS Electronic Health Record Association
6. Orlando Regional Medical Center (ORMC) Implements PNA FISH(R) Tests to Help Provide Better Care for Patients with Bloodstream Infections
7. Novasys Medical Receives $18.95 Million in Second Tranche of Series D Financing
8. Owensboro Medical Health System Announces Results of Its Modified Dutch Auction Tender Offer
9. HealthCare Partners of Nevada and Fremont Medical Center Join Forces
10. All Allied Health Schools Helps Medical Coding Students Prepare for New Health Care World
11. Growth in African Medical Imaging Markets: Frost & Sullivan Examines the Potential
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... Guruji Mahendra ... 9th, 10th and 11th, 2016 in honor of his birthday on February 10th. ... happiness. Mahendra Trivedi is known by over 250,000 people from over 40 different ...
(Date:2/7/2016)... ... February 07, 2016 , ... Women’s Excellence now ... the most minimally invasive approaches. , Women who have had multiple vaginal births ... factors include surgery to the pelvic floor, connective tissue disorders, and obesity. Women ...
(Date:2/7/2016)... ... February 07, 2016 , ... Dr. Todd Hobgood , ... medical and surgical expertise. Technically known as deoxycholic acid or previously as ATX-101, ... non-surgical alternative for reduction of fat below the chin (aka the “double chin”). ...
(Date:2/6/2016)... ... February 06, 2016 , ... With the FCPX ... warm color grades to their footage. A LUT is a Lookup Table that contains ... the corresponding color indicated by the table. By manipulating each pixel, LUT's can change ...
(Date:2/5/2016)... ... , ... Steven Tonkinson, 36, of Coconut Grove, Florida, ran the Miami Marathon ... 2003. This year, he ran all 26.2 miles with a green 25-pound ShelterBox strapped ... Heat. , This Sunday, while many are watching the Superbowl, Steven Tonkinson will strap ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... -- HemaFlo Therapeutics, Inc. announced today that the United States Patent ... covering the use of NephroFlow to treat acute kidney injury ... said, "We are pleased to secure our rights to such ... PhD, HemaFlo,s founder, said, "We are pleased to secure our ... Dale Peterson , PhD, HemaFlo,s founder, said, "We are ...
(Date:2/8/2016)... , Feb. 8, 2016  Dynatronics Corporation ... of advanced-technology medical devices and rehabilitation equipment for ... congratulates the Denver Broncos, football team for winning ... Cullimore Jr. , Chairman and Chief Executive Officer.  ... and we look forward to enhancing their athletic ...
(Date:2/8/2016)... , Feb. 8, 2016  Sangamo BioSciences, ... therapeutic genome editing, announced that the U.S. Food ... Investigational New Drug (IND) application for SB-318, a ... therapy for Mucopolysaccharidosis Type I (MPS I). The ... Sangamo to initiate a Phase 1/2 clinical study ...
Breaking Medicine Technology: